Cargando…

Identification of Small Molecule Enhancers of Immunotherapy for Melanoma

Small molecule based targeted therapies for the treatment of metastatic melanoma hold promise but responses are often not durable, and tumors frequently relapse. Response to adoptive cell transfer (ACT)-based immunotherapy in melanoma patients are durable but patients develop resistance primarily du...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dextras, Christopher, Dashnyam, Myagmarjav, Griner, Lesley A. Mathews, Sundaresan, Janani, Chim, Bryan, Yu, Zhiya, Vodnala, Suman, Lee, Chyi-Chia Richard, Hu, Xin, Southall, Noel, Marugan, Juan J., Jadhav, Ajit, Restifo, Nicholas P., Acquavella, Nicolas, Ferrer, Marc, Singh, Anju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105471/ https://www.ncbi.nlm.nih.gov/pubmed/32231230 http://dx.doi.org/10.1038/s41598-020-62369-1

Ejemplares similares

Anxiolytic Drug FGIN-1-27 Ameliorates Autoimmunity by Metabolic Reprogramming of Pathogenic Th17 Cells
por: Singh, Anju, et al.
Publicado: (2020)

Identification of Small Molecule Inhibitors of a Mir155 Transcriptional Reporter in Th17 Cells
por: Singh, Anju, et al.
Publicado: (2021)

Immunotherapy generates selective pressure for acquisition of immunogenic neoantigens in escape tumors
por: Pan, Jenny H, et al.
Publicado: (2015)

A High Throughput Screening Assay System for the Identification of Small Molecule Inhibitors of gsp
por: Bhattacharyya, Nisan, et al.
Publicado: (2014)

Efficacy and Mechanism of Action of Low Dose Emetine against Human Cytomegalovirus
por: Mukhopadhyay, Rupkatha, et al.
Publicado: (2016)

Discovery of small molecule inhibitors that effectively disrupt IQGAP1-Cdc42 interaction in breast cancer cells
por: Sayedyahossein, Samar, et al.
Publicado: (2022)

Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia
por: Tran, Eric, et al.
Publicado: (2013)

High-Throughput Multiplexed Quantitation of Protein Aggregation and Cytotoxicity in a Huntington’s Disease Model
por: Titus, Steven A, et al.
Publicado: (2012)

Host conditioning with IL-1β improves the antitumor function of adoptively transferred T cells
por: Lee, Ping-Hsien, et al.
Publicado: (2019)

Novel Patient Cell-Based HTS Assay for Identification of Small Molecules for a Lysosomal Storage Disease
por: Geng, Haifeng, et al.
Publicado: (2011)

SAT-035 Small Molecule Allosteric Agonist of Relaxin Receptor Ml290 Demonstrates Antifibrotic Properties in Liver Fibrosis
por: Kaftanovskaya, Elena, et al.
Publicado: (2019)

Pharmacokinetic evaluation of the PNC disassembler metarrestin in wild-type and Pdx1-Cre;LSL-Kras(G12D/+);Tp53(R172H/+) (KPC) mice, a genetically engineered model of pancreatic cancer
por: Vilimas, Tomas, et al.
Publicado: (2018)

Inhibition of Ceramide Metabolism Sensitizes Human Leukemia Cells to Inhibition of BCL2-Like Proteins
por: Casson, Lavona, et al.
Publicado: (2013)

High Throughput Screening for Inhibitors of Alpha-Galactosidase
por: Motabar, Omid, et al.
Publicado: (2010)

Identification of 4-phenylquinolin-2(1H)-one as a specific allosteric inhibitor of Akt
por: Huang, Bill X., et al.
Publicado: (2017)

Ionic immune suppression within the tumour microenvironment limits T cell effector function
por: Eil, Robert, et al.
Publicado: (2016)

High Throughput Screening for Small Molecule Therapy for Gaucher Disease Using Patient Tissue as the Source of Mutant Glucocerebrosidase
por: Goldin, Ehud, et al.
Publicado: (2012)

T cell receptor affinity and avidity defines antitumor response and autoimmunity in T cell immunotherapy
por: Krogsgaard, Michelle, et al.
Publicado: (2013)

High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: A drug repurposing strategy for advanced cancer
por: Datta, Amrita, et al.
Publicado: (2018)

Synaptamide activates the adhesion GPCR GPR110 (ADGRF1) through GAIN domain binding
por: Huang, Bill X., et al.
Publicado: (2020)

Engineering the immune response to "self" for effective cancer immunotherapy
por: Zhong, Shi, et al.
Publicado: (2014)

DPTIP, a newly identified potent brain penetrant neutral sphingomyelinase 2 inhibitor, regulates astrocyte-peripheral immune communication following brain inflammation
por: Rojas, Camilo, et al.
Publicado: (2018)

Chemical Screens Identify Drugs that Enhance or Mitigate Cellular Responses to Antibody-Toxin Fusion Proteins
por: Antignani, Antonella, et al.
Publicado: (2016)

Large-scale pharmacological profiling of 3D tumor models of cancer cells
por: Mathews Griner, Lesley A, et al.
Publicado: (2016)

Scaffolding Protein Connector Enhancer of Kinase Suppressor of Ras 1 (CNKSR1) Regulates MAPK Inhibition Responsiveness in Pancreas Cancer via Crosstalk with AKT Signaling
por: Li, Dandan, et al.
Publicado: (2023)

Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection
por: He, Shanshan, et al.
Publicado: (2015)

Activation of Relaxin Family Receptor 1 from Different Mammalian Species by Relaxin Peptide and Small-Molecule Agonist ML290
por: Huang, Zaohua, et al.
Publicado: (2015)

Agonist-specific voltage-dependent gating of lysosomal two-pore Na(+) channels
por: Zhang, Xiaoli, et al.
Publicado: (2019)

A Homogenous Luminescence Assay Reveals Novel Inhibitors for Giardia Lamblia Carbamate Kinase
por: Chen, Catherine Z, et al.
Publicado: (2012)

Enhancer RNA-based modeling of adverse events and objective responses of cancer immunotherapy reveals associated key enhancers and target genes
por: Guo, Mengbiao, et al.
Publicado: (2023)

Cancer genes disfavoring T cell immunity identified via integrated systems approach
por: Kishton, Rigel J., et al.
Publicado: (2022)

Epidemiologic studies of glyphosate and non-Hodgkin's lymphoma: A review with consideration of exposure frequency, systemic dose, and study quality
por: Acquavella, John
Publicado: (2023)

Mining the mutanome: developing highly personalized Immunotherapies based on mutational analysis of tumors
por: Overwijk, Willem W, et al.
Publicado: (2013)

Enhanced efficacy and limited systemic cytokine exposure with membrane-anchored interleukin-12 T-cell therapy in murine tumor models
por: Zhang, Ling, et al.
Publicado: (2020)

Compound Cytotoxicity Profiling Using Quantitative High-Throughput Screening
por: Xia, Menghang, et al.
Publicado: (2008)

The NCATS BioPlanet – An Integrated Platform for Exploring the Universe of Cellular Signaling Pathways for Toxicology, Systems Biology, and Chemical Genomics
por: Huang, Ruili, et al.
Publicado: (2019)

Quantitative analysis of organizational culture in occupational health research: a theory-based validation in 30 workplaces of the organizational culture profile instrument
por: Marchand, Alain, et al.
Publicado: (2013)

Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence
por: Vera-Ramirez, Laura, et al.
Publicado: (2018)

Future directions in epidemiologic studies of 1,3-butadiene-exposed workers.
por: Acquavella, J F
Publicado: (1990)

Durable Responses in Patients With Advanced Cholangiocarcinoma on Sequential Dual-agent Immunotherapy After Progressing on Single-agent Immunotherapy
por: Kaakour, Dalia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gklh4enhd6dqug1g5vp30ocmto